Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05904782 · ClinicalTrials.gov registry record

Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer

A clinical trial of Cancer, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
150
Enrollment target
1
Study location

NCT05904782: Recruiting study of Cancer, sponsored by M.D. Anderson Cancer Center.

NCT05904782 is a study of Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 150 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05904782, a study of Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

To learn more about the experience and wellbeing of people who provide care for cancer patients.

Conditions Studied

Study Locations (1)

Texas

  • The University of Texas M. D. Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-08-29
Est. Completion 2027-11-01
M.D. Anderson Cancer Center

2,692 total trials

What NCT05904782 shows while recruiting

NCT05904782 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT05904782 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05904782 about?

NCT05904782 is a clinical study titled "Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer". To learn more about the experience and wellbeing of people who provide care for cancer patients.

What is the current status of trial NCT05904782?

This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-08-29. Estimated completion is 2027-11-01.

What conditions does trial NCT05904782 study?

This clinical trial studies the following conditions: Cancer.

Who is sponsoring clinical trial NCT05904782?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05904782 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05904782's enrollment target sits among peer trials

150 264th of 615 higher than 346 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05904782, the US trial registry maintained by the National Library of Medicine. NCT05904782 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.